A Novel Assay Based on the Expression of ILT-3 (CD85k) by the 2 Major Circulating DC Subsets: Performance Validation
A Novel Assay Based on the Expression of ILT-3 (CD85k) by the 2 Major Circulating DC Subsets: Performance Validation
A Novel Assay Based on the Expression of ILT-3 (CD85k) by the 2 Major Circulating DC Subsets: Performance Validation
Simple solution for screening activity of purified or recombinant lysine specific demethylase enzymes
Inhibitor of bone resorption; Inhibits farnesyl diphosphate (FPP) synthase
Alturas Analytics is a CRO specializing in preclinical and clinical bioanalysis
Join this expert webinar to learn how to increase throughput in sample prep and qPCR
Visit booth No. 811 to discover the most flexible plate reader for assay development and more
Visit Binding Site at stand #8 or attend workshop on June 13
Blood banks will use the new test to screen donated blood in potential endemic areas of the US
FFPE reference control developed in collaboration with Horizon Discovery for use alongside Archer FusionPlex™ Panels